Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in cancer therapy

I Mercado1, L Baez, W Caceres

  • 1Internal Medicine Department, Universidad Central del Caribe, Bayamón, Puerto Rico 00960-6032.

Boletin De La Asociacion Medica De Puerto Rico
|July 1, 1997
PubMed
Summary

New chemotherapy drugs like taxanes, Vinorelbine, Irinotecan, Topotecan, Gemcitabine, and Gliadel offer improved cancer treatment options. Further research is essential to optimize their clinical application and patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioremediation of Cephalexin with non-living Chlorella sp., biomass after lipid extraction.

Bioresource technology·2018
Same author

Salmonella contamination during production of cantaloupe: a binational study.

Journal of food protection·2004
Same author

In-Plant evaluation of a lactic acid treatment for reduction of bacteria on chilled beef carcasses..

Journal of food protection·2001
Same author

Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer.

Urologic oncology·2001
Same author

Lactic acid sprays reduce bacterial pathogens on cold beef carcass surfaces and in subsequently produced ground beef.

Journal of food protection·2001
Same author

Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293).

American journal of clinical oncology·2000

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Therapeutics

Background:

  • Cancer treatment has evolved significantly since the early 20th century.
  • The development of alkylating agents during World War II marked a major advancement.
  • Recent years have seen the approval of several novel chemotherapeutic agents.

Purpose of the Study:

  • To review newly approved chemotherapeutic agents for cancer treatment.
  • To discuss the pharmacology, indications, and toxicity of these new drugs.
  • To provide guidance on appropriate dosing for these novel agents.

Main Methods:

  • Review of recent literature on new cancer drugs.
  • Analysis of pharmacological data, clinical indications, and toxicity profiles.
  • Compilation of dosing information for selected chemotherapeutic agents.

Main Results:

  • Introduction of taxanes (Docetaxel, Paclitaxel), Vinorelbine, Irinotecan, Topotecan, Gemcitabine, and Gliadel.
  • Detailed discussion of each agent's mechanism of action, therapeutic uses, and adverse effects.
  • Summary of recommended dosages and administration guidelines.

Conclusions:

  • The introduction of these new agents represents significant progress in cancer therapy.
  • Understanding their pharmacology and toxicity is crucial for effective clinical use.
  • Continued clinical research is necessary to establish optimal treatment strategies and improve patient outcomes.

Related Experiment Videos